Related Experiment Video
Updated: Jun 30, 2025

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
Proton Pump Inhibitors: Rational Use and Use-Reduction - The Windsor Workshop
Peter Kahrilas1, Foteini Anastasiou2, Albert J Bredenoord3
1Division of Gastroenterology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Reducing proton pump inhibitor (PPI) use requires patient education on alternatives and rational prescribing. Gradual dose tapering and on-demand therapy are effective PPI deprescribing strategies.
Area of Science:
- Gastroenterology
- Primary Care Medicine
- Pharmacology
Background:
- Proton pump inhibitor (PPI) overutilization persists despite deprescribing efforts.
- Meaningful reductions in PPI use remain a significant challenge in clinical practice.
Purpose of the Study:
- To define rational prescribing of PPIs.
- To identify appropriate candidates and timing for PPI use-reduction.
- To outline effective strategies for PPI deprescribing.
Main Methods:
- A comprehensive literature review was conducted.
- International primary care physicians and gastroenterologists collaborated.
- Key aspects of PPI use and reduction were analyzed.
Main Results:
- Rational PPI prescribing involves patient education on alternatives (diet, lifestyle, weight loss) before initiation.
- PPIs initiated at hospital discharge require re-evaluation for continued need.
- Long-term PPI therapy necessitates annual review.
Conclusions:
- PPI use-reduction should be based on lack of rational indication, not solely on adverse event concerns.
- Successful PPI deprescribing involves strategies like on-demand use or dose tapering with rescue therapy.
- Abrupt cessation of PPIs is less effective than gradual reduction.
More Related Videos
08:25Construction of a Wireless-Enabled Endoscopically Implantable Sensor for pH Monitoring with Zero-Bias Schottky Diode-based Receiver
Published on: August 27, 2021
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...